A U.S. cannabis company has approached Aurora Cannabis Inc., expressing interest in acquiring the Edmonton-based firm. Aurora has formed a special committee to review the unsolicited bid following an announcement by Curaleaf Holdings Inc. about its intention to purchase all shares of Aurora.
If successful, the acquisition would result in the formation of a combined cannabis entity with operations in 17 countries across Europe, North America, and other global markets, according to Curaleaf. The Connecticut-based company, listed on the Toronto Stock Exchange, decided to make its proposal public after unsuccessful private negotiations with Aurora’s leadership.
Curaleaf stated that despite sending formal letters of intent on June 23 and July 7 outlining the acquisition proposal, Aurora’s board declined to engage in discussions. Curaleaf’s CEO expressed disappointment at Aurora’s lack of meaningful engagement and emphasized the significant premium and strategic benefits of the deal.
Proposing to pay Aurora shareholders $4 US per share plus an additional $0.75 US in cash for each share, Curaleaf highlighted potential benefits from combining its global distribution network with Aurora’s established medical cannabis presence and production capabilities. The companies collectively generated over $1.5 billion US in revenue in the past year, with Curaleaf anticipating annual cost synergies of at least $40 million US from the acquisition.
Despite the interest from Curaleaf, Aurora emphasized that the current offer undervalues its long-term growth potential. Analysts also echoed this sentiment, citing Aurora’s market leadership, product portfolio, financial stability, and regulatory expertise as factors that could generate substantial value over time.
Aurora confirmed receiving the acquisition proposals from Curaleaf but disputed claims of refusing to engage with the offer. The company intends to assess the proposal through a special committee of independent directors to determine its impact on stakeholders’ interests. While no deal assurance is given, Aurora will continue its regular operations during the evaluation process.